The unique immune microenvironment of liver metastases: Challenges and opportunities.

Seminars in Cancer Biology
Aaron T CinerPnina Brodt

Abstract

Liver metastases from gastrointestinal and non-gastrointestinal malignancies remain a major cause of cancer-related mortality and a major clinical challenge. The liver has unique properties that facilitate metastatic expansion, including a complex immune system that evolved to dampen immunity to neoantigens entering the liver from the gut, through the portal circulation. In this review, we describe the unique microenvironment encountered by cancer cells in the liver, focusing on elements of the innate and adaptive immune response that can act as a double-edge sword, contributing to the elimination of cancer cells on the one hand and promoting their survival and growth, on the other. We discuss this microenvironment in a clinical context, particularly for colorectal carcinoma, and highlight how a better understanding of the role of the microenvironment has spurred an intense effort to develop novel and innovative strategies for targeting liver metastatic disease, some of which are currently being tested in the clinic.

References

Aug 12, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M M Borner
May 12, 2000·Immunological Reviews·D G Doherty, C O'Farrelly
May 12, 2000·Immunological Reviews·T AboH Watanabe
Mar 6, 2002·The Journal of Experimental Medicine·Jenny E GumperzMichael B Brenner
Apr 24, 2002·Science·Kamel BenlaghaAlbert Bendelac
Aug 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katja KlugewitzIan Nicholas Crispe
Jul 17, 2003·British Journal of Cancer·L WyldA J Evans
Jan 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sergei KusmartsevDmitry I Gabrilovich
Jan 27, 2004·The American Journal of Pathology·Sarah GoddardDavid H Adams
Sep 24, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ke QiF William Orr
Sep 24, 2004·International Journal of Cancer. Journal International Du Cancer·Maarten TimmersFilip Braet
Feb 25, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Venu G PillarisettyRonald P Dematteo
Apr 1, 2005·PLoS Biology·Frederic GeissmannDan R Littman
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ilia N BuhtoiarovAlexander L Rakhmilevich
Aug 25, 2005·Journal of Surgical Oncology·S R WalshN J Keeling
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Vito Racanelli, Barbara Rehermann
Apr 28, 2006·Nature·Janine T ErlerAmato J Giaccia
Sep 16, 2006·Immunological Reviews·Ian N CrispeSherry Wuensch
Mar 3, 2007·Journal of Leukocyte Biology·Li ChenJian-Xin Gao
Mar 22, 2007·Expert Opinion on Biological Therapy·Ravi A MadanJames L Gulley
Aug 1, 2007·Nature Biotechnology·Farbod ShojaeiNapoleone Ferrara
Oct 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James S TomlinsonMichael D'Angelica
Jan 29, 2008·Inflammation & Allergy Drug Targets·Fabricia PetronilhoFelipe Dal Pizzol
Mar 18, 2008·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Georgios LyratzopoulosJulia Yelloly
Jul 18, 2008·Nature Reviews. Cancer·Craig MurdochClaire E Lewis
Aug 21, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Qiang YouCynthia Ju
Oct 24, 2008·The New England Journal of Medicine·Christos S KarapetisJohn R Zalcberg
Feb 7, 2009·Nature Reviews. Immunology·Dmitry I Gabrilovich, Srinivas Nagaraj
Feb 10, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zubin M BamboatRonald P DeMatteo
Mar 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·René AdamDenis Castaing
Mar 24, 2009·Annual Review of Immunology·Ian Nicholas Crispe
Mar 25, 2009·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Fernando Vidal-Vanaclocha
Apr 3, 2009·The New England Journal of Medicine·Eric Van CutsemPhilippe Rougier
Apr 4, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Suzanne Ostrand-Rosenberg, Pratima Sinha
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hai HuYuliang Ran
Sep 1, 2009·Journal of Autoimmunity·Gisa Tiegs, Ansgar W Lohse
Oct 24, 2009·Nature Reviews. Cancer·Hua YuRichard Jove
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Takanori KitamuraMakoto M Taketo

❮ Previous
Next ❯

Citations

Nov 26, 2020·Journal of Cancer Research and Clinical Oncology·Zelin HouHeguang Huang
Feb 7, 2021·International Journal of Molecular Sciences·Gemma Garcia-ViciénDavid G Molleví
Apr 17, 2021·Nature Reviews. Disease Primers·Diamantis I TsilimigrasTimothy M Pawlik
Jul 31, 2021·Nature Reviews. Cancer·Xin LiMathias Heikenwalder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.